DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Long GV, Dummer R, Ribas A. et al.
A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265).
J Immun Therap Cancer 2015;
3: P181
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.